Abstract-Acute kidney injury (AKI) is characterised by a rapid deterioration in kidney function, and can be identified by examining the rate of change in a patient's estimated glomerular filtration rate (eGFR) signal. Due to the potentially irreversible nature of the damage AKI episodes cause to renal function, their detection plays a significant role in predicting a kidney's effectiveness. Although algorithms for the detection of AKI are available for patients under constant monitoring, e.g. inpatients, their applicability to primary care settings is less clear as the eGFR signal often contains large lapses in time between measurements. However, waiting for hospital admittance before AKI is undesirable, as detecting AKI early can help to mitigate the degradation of kidney function and the associated increase in morbidity and mortality. Traditionally, a clinician in a primary care setting would manually identify AKI episodes from direct observation of eGFR signals. While this approach may work for individual patients, the time consuming nature of it precludes quick large-scale monitoring. We therefore present two alternative automated approaches for detecting AKI: as the outlier points when using Gaussian process regression and using a novel technique we entitle Surrey AKI detection algorithm (SAKIDA). Using SAKIDA, we can identify the number of AKI episodes a patient experiences with an accuracy of 70%, when evaluated against the performance of human experts.
I. INTRODUCTION
Estimated glomerular filtration rate (eGFR) is a derived measurement of kidney function. Notwithstanding its limitations [1] plays a central role in both the management of people with chronic diseases and epidemiology research involving longitudinal data [2] , [3] . While across a population eGFR signal will in general display a gentle downward trend, for individuals it fluctuates considerably, as the measure of renal function also reflects protein metabolism. Acute kidney injuries (AKIs), is a substantial decline in kidney function beyond normal variability and leads to a failure to maintain a normal electrolyte balance, organ damage and increased mortality [4] - [6] . AKI can occur in any clinical setting, and costs the NHS in England approximately 1 billion per year [7] .
To facilitate chronic disease management in England, general practices are electronically connected to laboratories and laboratory test results [8] , [9] . As a result, eGFR can be directly monitored from these practices. However, for most of these patients, their eGFR values are measured infrequently and often irregularly. In contrast, the kidney function of inpatients is monitored more closely, in order to avoid missing AKI, particularly on admission to hospital [10] . Given this closer monitoring and the greater prevalence of AKI amongst inpatients [11] , algorithms have been developed that can accurately identify AKI within this population in real-time [12] , [13] . While this will improve outcomes for inpatients, approximately two thirds of AKI episodes are community acquired, i.e. occur outside hospitals, and therefore while the patient is under primary care [14] . Given the better short-and long-term outcomes, including reduced mortality, for patients with community acquired AKI [14] , [15] , robust detection of AKI within a primary care setting could substantially improve patient outcomes.
Despite the clear benefits derived from identification of AKI in the community, algorithms have not been developed to specifically address this. At present, a clinician can only identify AKI, through their interpretation of results as they review them case-by-case. While this may work for individual patients, an automated expert system triggering specialist review may be more reliable. Although the algorithms developed for hospitalised patients can (and will) be extended to primary care, their reliance on a baseline value estimated from recent measurements makes identification of AKI harder in primary care settings, where eGFR signals often contains large lapses in time between measurements.
In this study, three methods for identifying AKI episodes from indrividual patient's eGFR signal are evaluated against the performance of clinical experts. The first method was developed by NHS England to provide real-time detection and diagnosis of AKI in patients across the National Health Service in England [12] . However, applying it to primary care data can be problematic as it relies on calculating a baseline eGFR value for a patient from their measurements over the last 0-7 or 8-365 days. Given that a patient in primary care may only have a few measurements in the last year, and likely none in the last week, there may be too few measurements in the format required by the algorithm available to determine a reliable baseline. Similarly, if the patient had AKI in the last year, then the baseline calculation will take into account this period of decreased eGFR, thereby reducing the baseline below its true value and making it more difficult to identify AKI episodes. Additionally, as the algorithm is intended to serve as a real-time warning system, without alteration it is unsuitable for retrospective analysis of an eGFR signal, for example when attempting to identify all AKI episodes a patient has experienced, which may require knowledge of their risk of susceptibility to further decline in kidney function or kidney failure.
The second and third methods evaluated here are the Gaussian process regression (GPR) and the novel Surrey AKI detection algorithm (SAKIDA). They are intended not only to be able to provide real-time warnings, but also to be more applicable to a primary care setting and be inherently suitable for retrospective analysis. Previously we have used GPR to classify the overall trend in an eGFR signal [16] . In a similar manner, it can be used to identify AKI episodes by modelling an eGFR signal without them, and then treating any measurements less than the lower confidence limit as AKI episodes. This approach also has the advantage of giving a global trend for a patients eGFR signal, thereby obviating the need to calculate a timewindowed baseline against which AKI episodes are identified. The final method evaluated was the novel SAKIDA method. Similar to the GPR-based approach, SAKIDA enables retrospective analysis of an entire eGFR signal and can handle the irregularity of primary care eGFR signals. An example of these algorithms applied to a patient's 978-1-5090-4240-1/16/$31.00 ©2016 IEEE entire eGFR signal can be seen in Figure 1 . Given the need for algorithms that can identify AKI episodes in primary care settings and tools to assist non-specialist clinicians in identifying eGFR abnormalities, including AKI episodes, our contributions can be summarised as follows:
1)
Proposal and evaluation of novel AKI detection algorithms suitable for primary care data. While outlier detection using GPR is not new, formulating AKI identification as an outlier detection task is. Additionally, in order to generalise the confidence intervals reliably in our application we tune the GPR parameters in a supervised manner, something which to the best of our knowledge has not been reported before.
2)
We introduce SAKIDA, a medically inspired algorithm specifically designed to identify AKI episodes in eGFR signals from primary care data.
3)
Improved understanding for GPs. Utilising the ability of GPR to provide both predicted values and confidence interval bounds means that GPs can visualise an eGFR signal as stable or unstable [16] , while also identifying outlier measurements as potential AKI episodes. Alternatively, a hybrid algorithm consisting of GPR and SAKIDA could be used to visualise eGFR signal stability (GPR) and also localise AKI episodes (SAKIDA).
The organisation of the paper is as follows: In section II, we present and analyse our dataset and illustrate the demographics of the data. In section III, we present the GPR and SAKIDA methodology used in this paper. Experiments and results are discussed in section IV. Finally, in section V, we draw conclusions and discuss their relevance.
II. THE 'HANNAH' DATASET
The dataset used in this work contains the eGFR time signal of 488 patients (275 (56.4%) male and 213 (43.6%) female) treated at East Kent University Hospital, and was collected as part of a study seeking to understand the characteristics of acute kidney injury and its impact on chronic kidney disease. Each patient's eGFR time signal was labelled with the number of AKI episodes experienced: 0, 1, 2, 3 or 4. The distribution of the number of AKI episodes across the 488 patients is given in Table I and Figure 2 (h). In total, there were 10,873 eGFR measurements across the 488 patients, with approximately 95% between the values of 25 and 95 mL/min/ 1.73m 2 and occurring in patients between the ages of 60 and 90. Figure 2 summarises the main characteristics of the dataset. III. METHODS
A. Gaussian Process Regression
A Gaussian process is a collection of random variables, any finite collection of which has a joint Gaussian distribution [17] . GPs characterise the probability distribution over functions by a specified mean functiond(x) and a covariance function k(x, x ) [18] .
To describe a real process f (x) as a GP, we write:
where E{g(x)} denotes the expectation of a function g over the variable x.
Given a set of measurements
, the goal is to estimate the true output d(x * ) at an arbitrary x * given the relation:
The prior distribution of the observed target d(x) is given by:
where k(X, X ) is the covariance matrix between all pairs of training points. A squared exponential kernel was used to determine the covariance matrix, where the squared exponential kernel (Gaussian/RBF) is defined as: κ(x, x ) = exp(
, with γ the length scale of the kernel.
The distribution of the estimated mean value d(x) can be computed by conditioning on the training data to get p(d(x)|x * , D). The joint distribution over d(x) and the new datapoint x * is computed using:
Here,
The conditional distribution of Equation 2 allows us to get the distribution of d(x * ) with the following mean and covariance:
where
The GPstuff toolbox 1 [19] , was used for modelling the eGFR time signals, with the hyperparameters for the squared exponential kernel tuned using maximum a posteriori estimates.
1) Detecting AKIs as GPR outliers:
Let G be the set containing the eGFR signals from all 488 patients and
] denote the sets of eGFR signals containing 0, 1, 2, 3 and 4 AKI episodes as labelled by the human experts. In order to obtain the right confidence intervals to detect the AKI episodes as outliers, we trained the GPR using those patients that have no AKI present in their eGFR signals. Therefore, the dataset was partitioned into training and test sets as follows:
. The GPR was therefore trained using 10% of the 272 patients without an AKI episode. We set the initial parameters U, and trained the regressor to obtain the updated hyperparametersÛ using maximum a posteriori estimates. Later, using these updated hyper parametersÛ, we predict the number of AKI episodes for each eGFR signal in G test . The mean E{x * } and variance var{x * } for each eGFR signal is then calculated, and the 95% confidence intervals calculated as E{d(x * )} ± 2 × var{d(x * )}. The eGFR datapoints lying outside these confidence intervals are then determined to have been measured during an AKI episode.
B. Surrey AKI Detection Algorithm (SAKIDA)
Let x ≡ [x 1 , x 3 , . . . , x m ] be an eGFR signal of length m. Since, we are interested in finding the local minima (i.e., the points where there is a sudden drop in eGFR signal), we calculate the difference between adjacent elements, of the signal. For this purpose, 1 and −1 are appended to the left and right side of eGFR signal respectively.
The differences between adjacent datapoints are then calculated as:
Any index i in x can then be considered a local minima if x [i] is positive and x [i−1] negative. Let J = [j 1 , j 2 , . . . , j r ] be the indices of these local minima, i.e.
In order to calculate the rate of change for the first local minima, a 1 is prepended to J 2 . The rate of change r j at a local minima x [J [j] ] is then calculated as the ratio of the median value of the datapoints in
, ∀j ∈ {2, . . . , |J |}.
(7) where x [J [i] ] returns the value of x (the original sequence) at index J [i] .
Finally, the indices J AKI at which the rate of change is greater than or equal to a threshold ∆ are recorded as being an AKI episode.
The overall processing steps are shown in Algorithm 1.
C. Groundtruth & Evaluation Criteria
Each eGFR time-signal in the dataset was annotated by a nephrologist to record whether it contained 0, 1, 2, 3 or 4 AKI episodes. Taking y to be the groundtruth andŷ the labels predicted by an algorithm, we evaluated the performance of our proposed algorithms against the experts in the following ways: (i) percentage of correctly labelled eGFR signals (y =ŷ), (ii) percentage of signals where the algorithm predicted fewer AKI episodes than the experts (y >ŷ), (iii) percentage of signals where the algorithm predicted a greater number of AKI episodes than the experts (y <ŷ) and (iv) the accuracy with
return J AKI end which the algorithm was able to label signals subdivided by the number of AKI episodes (y [j] =ŷ [j] , ∀j ∈ {0, 1, 2, 3, 4}).
IV. EXPERIMENTS AND RESULTS
• Performance of GPR on the training set: Prior to performing outlier detection for identifying AKI episodes, the performance of the GPR algorithm when detecting no AKI episodes was evaluated. For this purpose, only those patients without an AKI episodes in their eGFR signal were considered. The GPR algorithm was trained on 10% of these patients, and evaluated on the remainder.
• Effect of the threshold on SAKIDA performance: According to the NICE guidelines, an AKI episode occurs when the ratio of the reference value calculated from prior measurements to the current measurement is ≥ 1.5. However, this threshold is designed for serum creatinine levels, not the eGFR values derived from them. In order to determine how this threshold influences the algorithms within the eGFR space, thresholds within the set {1.1, 1.2, . . . , 2.0} were evaluated, with the expectation that a threshold around 1.5 will perform best.
• Comparison of SAKIDA with GPR and NHS England: In order to determine the algorithm most suitable for detecting AKI episodes within a patient's entire eGFR signal, the performance of SAKIDA was compared to that of GPR and the NHS England algorithm in terms of their ability to mimic the labelling of the expert nephrologists.
A. Performance of GPR on the training set
As the detection of AKI episodes via GPR is reliant on AKI episodes being outliers, and the confidence intervals for determining this are dependent on the model learnt using patients with no AKI episodes, it is worth first assessing the performance of GPR on these patients. Since 10% of the patients with no AKI episodes were to be used for training the final GPR AKI detection model, the same set of patients was used when evaluating the ability of GPR to identify patients without AKI episodes. The models trained via 5-fold cross validation using this set of patients achieved a mean accuracy of 89% ± 1.2.
B. Effect of the threshold on SAKIDA performance
The results of varying the value of the ∆ parameter to take on values in the set {1.1, 1.2, . .., 2.0} can be seen in Table II . The conjecture that a threshold of ∆ ≥ 1.5 should perform well is borne out by the results, as it results in the algorithm predicting the number of AKI events most accurately (69.67%). However, it can be seen from Figure 3 that whereas SAKIDA's performance when evaluated for y =ŷ peaks at a threshold of 1.5, the performance of the NHS England algorithm continues to rise even when the threshold reaches 2.0. Threshold: ∆ 
E. Hybrid visualisation of SAKIDA & GPR
A hybrid system consisting of GPR and SAKIDA could improve clinicians' understanding of the eGFR signal. As GPR is able to provide both predicted values and confidence interval bounds, GPs can help to visualise and classify an eGFR signal as stable or unstable, thereby enabling clinicians to identify patients who are likely to need further monitoring (those with unstable eGFR signals). Additionally, the outliers can be used to identify regions of time where an AKI episode is likely to be occurring or have occurred, while SAKIDA can be used to localise the AKI episodes as shown in Figure 6 . 
V. CONCLUSIONS & DISCUSSIONS
Considering the severity of the complications arising from it, and the benefits of pre-hospital diagnosis, little attention has been given to improving the detection of AKI within the primary care setting. As most patients will have their health managed in their general practices for the majority of their lives, with hospital admittance possibly not occurring until long after an AKI episode, robust algorithms for real-time warning and retrospective identification of AKI episodes in primary care data are needed. However, primary care data presents a unique challenge, especially when compared with data collected in hospitals. Unlike the constant monitoring of an inpatient, patients in primary care will likely have less frequent and more irregular eGFR measurements along with a greater variability in eGFR values due to weaker controls over pre-test conditions. As demonstrated here, this can prove problematic for algorithms, such as the NHS England algorithm, that rely on the underlying biomedical condition being accurately captured via repeated and frequent measurements. Alternatively, algorithms that treat the AKI episode detection problem as one of signal processing, such as SAKIDA and GPR, fare better.
The main conclusion that can be drawn from the results is that SAKIDA performs better than both GPR and the NHS England algorithms, not only due to the greater accuracy with which it identifies patients with no AKI episodes, but also because it better matches the expert's classifications overall. This indicates that GPR and the NHS England algorithms are likely to be unsuitable for retrospective identification of AKI episodes in eGFR signals from primary care, and are instead more suitable as real-time alert systems. However, while a medical alert system that errs on the side of caution is likely preferable to one that fails to identify risks, our results indicate that both GPR and the NHS England algorithms simultaneously over and under predict the number of AKI episodes. Both methods identify more patients than the experts did as having no AKI episodes, while for 67 patients in the case of GPR and 99 in the case of NHS England too many AKI episodes are detected. Given that SAKIDA closely matches the expert's predictions and can be used for both retrospective analysis and real-time alerts, we believe it should be the method of choice when identifying AKI episodes within primary care data.
